Previous Article | Next Article 
Journal of Clinical Microbiology, February 2000, p. 702-707, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Line Probe Assay for Monitoring Drug Resistance in
Hepatitis B Virus-Infected Patients during Antiviral Therapy
Lieven
Stuyver,1,
Caroline
Van
Geyt,1,*
Sija
De
Gendt,1
Georges
Van
Reybroeck,1
Fabien
Zoulim,2
Geert
Leroux-Roels,3 and
Rudi
Rossau1
Innogenetics, N.V.,1
and Department of Clinical Chemistry, University
Hospital,3 Ghent, Belgium; and INSERM
U271, Lyon, France2
Received 6 July 1999/Returned for modification 21 September
1999/Accepted 3 November 1999
Since the introduction of antiviral compounds such as lamivudine
and famciclovir in the treatment schedules of patients with chronic
hepatitis B virus (HBV) infection, the accumulation of a variety of
mutations in the HBV polymerase gene has been observed. The selection
of these mutations is generally considered the cause of viral
nonresponsiveness and treatment failure. Therefore, the detection of
these mutations is of clinical importance. Previously genotyped HBV
strains isolated from treated and untreated patients were amplified
with primers specific for the HBV polymerase region from amino acids
465 to 562. Amplified products were cloned into plasmid vectors. The
clones were used as reference strains. A set of 38 highly specific
oligonucleotide probes covering three different codon positions, L528M,
M552V/I, and V/L/M555I, were selected. These probes were applied as 19 different lines on a membrane strip. The strips were then hybridized
with PCR fragments from the reference panel, revealing the amino acids
at the three codon positions simultaneously for each clone. PCR
products generated from two patients infected with HBV genotypes A and
C, respectively, and treated with nucleoside analogs were analyzed on
these strips. A gradual increase in genetic HBV polymerase complexity
was observed in follow-up samples compared to that in pretreatment
samples. Additional analysis of HBV polymerase DNA fragments in
recombinant plasmid clones demonstrated the existence of (i) clones
with double mutations, (ii) clones with single mutations at either
codon 528, 552, or 555, and (iii) the simultaneous occurrence of two or
more viral populations within one sample. This line probe assay
detected the complex quasispecies nature of HBV and provided some
insight into the dynamics of resistance mutations.
*
Corresponding author. Mailing address: Innogenetics,
N.V., Industriepark 7, Box 4, 9052 Ghent, Belgium. Phone: (32) 9 2410 711. Fax: (32) 9 2410 907.

Present address: Pharmasset, Inc., Tucker, GA
30084.
Journal of Clinical Microbiology, February 2000, p. 702-707, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yoshida, S., Hige, S., Yoshida, M., Yamashita, N., Fujisawa, S.-i., Sato, K., Kitamura, T., Nishimura, M., Chuma, M., Asaka, M., Chiba, H.
(2008). Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B. Ann Clin Biochem
45: 59-64
[Abstract]
[Full Text]
-
Alvarado-Esquivel, C., de la Ascension Carrera-Gracia, M., Conde-Gonzalez, C. J., Juarez-Figueroa, L., Ruiz-Maya, L., Aguilar-Benavides, S., Torres-Valenzuela, A., Sablon, E.
(2006). Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico. J Antimicrob Chemother
57: 221-223
[Abstract]
[Full Text]
-
Ou, Z.-Y., Liu, N., Chen, C.-J., Cheng, G., He, Y.-S.
(2005). Rapid and Accurate Genotyping of YMDD Motif Variants in the Hepatitis B Virus Genome by an Improved Reverse Dot Blot Method. J. Clin. Microbiol.
43: 5685-5689
[Abstract]
[Full Text]
-
Wightman, F., Walters, T., Ayres, A., Bowden, S., Bartholomeusz, A., Lau, D., Locarnini, S., Lewin, S. R.
(2004). Comparison of Sequence Analysis and a Novel Discriminatory Real-Time PCR Assay for Detection and Quantification of Lamivudine-Resistant Hepatitis B Virus Strains. J. Clin. Microbiol.
42: 3809-3812
[Abstract]
[Full Text]
-
Osiowy, C., Giles, E.
(2003). Evaluation of the INNO-LiPA HBV Genotyping Assay for Determination of Hepatitis B Virus Genotype. J. Clin. Microbiol.
41: 5473-5477
[Abstract]
[Full Text]
-
Hussain, M., Chu, C.-J., Sablon, E., Lok, A. S. F.
(2003). Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants. J. Clin. Microbiol.
41: 3699-3705
[Abstract]
[Full Text]
-
Kessler, H. H., Stelzl, E., Marth, E., Stauber, R. E.
(2003). Detection of Mutations in the Hepatitis B Virus Polymerase Gene. Clin. Chem.
49: 989-992
[Full Text]
-
NIESTERS, H. G. M., DE MAN, R. A., PAS, S. D., FRIES, E., OSTERHAUS, A. D. M. E.
(2002). Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J Med Microbiol
51: 695-699
[Abstract]
[Full Text]
-
Gobbers, E., Oosterlaken, T. A. M., van Bussel, M. J. A. W. M., Melsert, R., Kroes, A. C. M., Claas, E. C. J.
(2001). Efficient Extraction of Virus DNA by NucliSens Extractor Allows Sensitive Detection of Hepatitis B Virus by PCR. J. Clin. Microbiol.
39: 4339-4343
[Abstract]
[Full Text]
-
Aberle, S. W., Kletzmayr, J., Watschinger, B., Schmied, B., Vetter, N., Puchhammer-Stöckl, E.
(2001). Comparison of Sequence Analysis and the INNO-LiPA HBV DR Line Probe Assay for Detection of Lamivudine-Resistant Hepatitis B Virus Strains in Patients under Various Clinical Conditions. J. Clin. Microbiol.
39: 1972-1974
[Abstract]
[Full Text]